Related Experiment Video

Updated: Jul 5, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

[Pyogenic vertebral osteomyelitis]

Hideto Machida1

  • 1Kanto Rosai Hospital, Department of Orthopedic Surgery.

Clinical Calcium
|May 1, 2008
PubMed

Insights

Pyogenic vertebral osteomyelitis, a serious spinal infection, has seen improved outcomes due to medical advances. However, rising cases in older, immunocompromised patients with resistant bacteria present ongoing management challenges.

Area of Science:

  • Infectious Diseases
  • Orthopedic Surgery
  • Microbiology

Context:

  • Pyogenic vertebral osteomyelitis (PVO) historically carried high morbidity and mortality.
  • Recent advancements in diagnostics, antimicrobial chemotherapy, and surgical techniques have improved PVO prognosis.
  • An increasing incidence of PVO is observed, linked to an aging population, immunocompromised hosts, and the rise of resistant bacteria.

Purpose:

  • To review the current management strategies for pyogenic vertebral osteomyelitis.
  • To highlight the challenges posed by increasing patient complexity and antimicrobial resistance.
  • To emphasize the importance of early diagnosis, appropriate antimicrobial therapy, and timely surgical intervention when indicated.

Summary:

  • Despite improved treatments, PVO management remains complex due to demographic shifts and evolving microbial resistance.
  • Early diagnosis and identification of the causative organism are crucial for effective antimicrobial chemotherapy.
  • Multidisciplinary collaboration, particularly with spinal surgeons, is essential for optimizing treatment outcomes, including surgical intervention when necessary.

Impact:

  • Improved understanding of PVO management in the context of modern healthcare challenges.
  • Guidance for clinicians on the critical role of early diagnosis and tailored antimicrobial and surgical strategies.
  • Potential for reduced morbidity and mortality through optimized, evidence-based PVO treatment protocols.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...